Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...
Sanofi's Mixed Fortunes in MS Drug Trials Has Market Focus on Win By Ludwig Burger (Reuters) -Sanofi's most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage ...
Some results have been hidden because they may be inaccessible to you